Schedule 13D ownership disclosure

AEROVATE THERAPEUTICS INC

Security class unavailable · CUSIP: 008064107

Event date: 2022-11-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,758,686
Percent of class
15.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-010758
Form type
SC 13D/A
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
Feb 06, 2023
Reporting period
Nov 14, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub